Back
GoodRx Holdings Quote, Financials, Valuation and Earnings
Sponsored
GDRX
Sponsored
Election Shock on August 19th?
Click here now to see the evidence I've gathered.
Sell
38
GDRX
GoodRx Holdings
Last Price:
6.69
Seasonality Move:
19.17%
7 Day Trial
ALL ACCESS PASS
$
7
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.GoodRx Holdings Price Quote
$6.69
-0.01 (-0.15%)
(Updated: May 14, 2024 at 3:30 PM ET)
GoodRx Holdings Key Stats
Sell
38
GoodRx Holdings (GDRX)
is a Sell
Day range:
$6.57 - $6.86
52-week range:
$4.14 - $9.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.55
P/B ratio:
3.98%
Volume:
1M
Avg. volume:
1.1M
1-year change:
31.37%
Market cap:
$2.5B
Revenue:
$750.3M
EPS:
$-0.01
How Much Does GoodRx Holdings Make?
-
How Much Are GoodRx Holdings's Sales Annually?
GDRX Revenues are $750.3M -
How Much Profit Does GoodRx Holdings's Make A Year?
GDRX net income is -$8.9M
Is GoodRx Holdings Growing As A Company?
-
What Is GoodRx Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.08% -
What Is GoodRx Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
GoodRx Holdings Stock Price Performance
-
Did GoodRx Holdings Stock Go Up Last Month?
GoodRx Holdings share price went down by -1.9% last month -
Did GDRX's Share Price Rise Over The Last Year?
GDRX share price rose by 31.37% over the past 1 year
What Is GoodRx Holdings 52-Week High & Low?
-
What Is GoodRx Holdings’s 52-Week High Share Price?
GoodRx Holdings has traded as high as $9.37 over the past 52 weeks -
What Is GoodRx Holdings’s 52-Week Low Share Price?
GoodRx Holdings has traded as low as $4.14 over the past 52 weeks
GoodRx Holdings Price To Free Cash Flow
-
Is GoodRx Holdings Stock Overvalued?
GoodRx Holdings is trading at a price to free cash flow ratio of 31.39 -
Is GoodRx Holdings Stock Undervalued?
GoodRx Holdings EV to Free Cash Flow ratio is 30.46 -
What Is GoodRx Holdings’s Price Earnings Growth Ratio?
GDRX PEG ratio is 0.00 -
Is GoodRx Holdings Trading At A Premium To Earnings?
GoodRx Holdings EV to EBIT ratio is 0.00
Is It Risky To Buy GoodRx Holdings?
-
How Much Debt Does GoodRx Holdings Have?
Total long term debt quarterly is $653.7M -
How Much Cash Does GoodRx Holdings Have?
Cash and short term investments quarterly total is $533.3M -
What Is GoodRx Holdings’s Book Value Per Share?
Book value per share is 1.68
Is GoodRx Holdings Cash Flow Positive?
-
What Is GDRX Cash Flow From Operations?
Cash flow from operations (TTM) is $148.6M -
What Is GoodRx Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$314.3M -
What Is GoodRx Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$62.1M
GoodRx Holdings Return On Invested Capital
-
Is Management Doing A Good Job?
GDRX return on invested capital is -0.45% -
What Is GoodRx Holdings Return On Assets?
ROA measures how assets are converting to revenues and is -0.41% -
What Is GDRX Return On Equity?
ROE is a measure of profitability and is -0.82%
GoodRx Holdings Earnings Date & Stock Price
-
What Is GoodRx Holdings's Stock Price Today?
A single share of GDRX can be purchased today for 6.70 -
What Is GoodRx Holdings’s Stock Symbol?
GoodRx Holdings trades on the nasdaq under the ticker symbol: GDRX -
When Is GoodRx Holdings’s Next Earnings Date?
The next quarterly earnings date for GoodRx Holdings is scheduled on August 9, 2024 -
When Is GDRX's next ex-dividend date?
GoodRx Holdings's next ex-dividend date is May 14, 2024 -
How To Buy GoodRx Holdings Stock?
You can buy GoodRx Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
GoodRx Holdings Competitors
-
Who Are GoodRx Holdings's Competitors?
Below is a list of companies who compete with GoodRx Holdings or are related in some way:
GoodRx Holdings Dividend Yield
Data Unavailable
GoodRx Holdings Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 5.58% |
Revenue: | 7.55% | 0.91% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 9 |
Sell Recommendations: | 0 |
Price Target: | 8.38 |
Upside from Last Price: | 25.11% |